These three medtech companies are at the forefront of diabetes care.
News & Analysis: Tandem Diabetes Care
The business reported first-quarter 2019 earnings -- and more positive news since.
Worries about what might happen with the U.S. healthcare system took a toll on the insulin-pump maker's share price.
Shares of the insulin pump maker have gained a whopping 1,490% over the last year.
Shares jumped after the company reported blowout fourth-quarter results and issued bullish guidance. Here's what investors need to know.
This insulin pump maker launched a revolutionary new treatment option for type 1 patients.
Shares tumble on a slow news day. What can explain the double-digit move?
The insulin pump maker won key support from Wall Street this morning.
Shares dropped by double digits on Monday. What's going on?
Strong Q2 earnings results from earlier in the week keep the momentum going for the insulin-pump maker.
The insulin pump maker's second-quarter financials are sparking optimism.